AKCEA THERAPEUTICS INC's ticker is AKCA and the CUSIP is 00972L107. A total of 1 filers reported holding AKCEA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $8,126,000 | +857.1% | 447,981 | +623.2% | 0.00% | – |
| Q2 2020 | $849,000 | +68.5% | 61,943 | +75.8% | 0.00% | – |
| Q1 2020 | $504,000 | -39.3% | 35,238 | -28.2% | 0.00% | – |
| Q4 2019 | $830,000 | +111.2% | 49,074 | +91.9% | 0.00% | – |
| Q3 2019 | $393,000 | -57.7% | 25,570 | -35.4% | 0.00% | – |
| Q2 2019 | $929,000 | -5.8% | 39,583 | +13.8% | 0.00% | – |
| Q1 2019 | $986,000 | +146.5% | 34,794 | +162.1% | 0.00% | – |
| Q4 2018 | $400,000 | -57.5% | 13,276 | -50.7% | 0.00% | – |
| Q3 2018 | $942,000 | +16.7% | 26,904 | -21.0% | 0.00% | – |
| Q2 2018 | $807,000 | +32.1% | 34,052 | +42.7% | 0.00% | – |
| Q1 2018 | $611,000 | +8.5% | 23,865 | -26.3% | 0.00% | – |
| Q4 2017 | $563,000 | +153.6% | 32,396 | +304.6% | 0.00% | – |
| Q3 2017 | $222,000 | – | 8,007 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 2,389,571 | $61,197,000 | 1.69% |
| Virtus ETF Advisers LLC | 39,351 | $1,008,000 | 0.88% |
| Eventide Asset Management | 175,000 | $4,482,000 | 0.21% |
| ALTRINSIC GLOBAL ADVISORS LLC | 187,800 | $4,810,000 | 0.19% |
| Bellevue Group AG | 48,799 | $1,250,000 | 0.12% |
| Perceptive Advisors | 97,144 | $2,488,000 | 0.07% |
| FMR LLC | 10,008,016 | $256,306,000 | 0.03% |
| WELLINGTON MANAGEMENT GROUP LLP | 3,384,101 | $86,667,000 | 0.02% |
| Virtu Financial LLC | 12,571 | $322,000 | 0.02% |
| Cubist Systematic Strategies, LLC | 7,843 | $201,000 | 0.01% |